SUBSCRIBE
SUBSCRIBE
News   Business

Gentium S.p.A. Reports Third Quarter Financial Results And Clinical Update

November 30, 2006 | 
1 min read
VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (Nasdaq:GENT) (the “Company”) today reported financial results for the three and nine months ended September 30, 2006. Highlights of the third quarter of 2006 and recent weeks include:
Earnings Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Merck To Cut 125 Employees as It Ends UK R&D Work
September 12, 2025
 · 
198 min read
 · 
BioSpace Editorial Staff
AbbVie headquarters building facade of an American publicly traded biopharmaceutical company. - South San Francisco, California, USA - 2021
Patents
AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
 · 
2 min read
 · 
Annalee Armstrong